Is the phase 2 data for AT13387 W/Gleevec still due this month? I have not heard much about it but according to clinicaltrials.gov the study completion date is August 2013. Anyone know something I don't know?
The short answer is I don't know. Still, it seems that if a study only just completed in
August, it might be a bit soon to expect any analysis of the data,